Metraipolis › archive › dc_dc8322d7af64

Systematic review and meta-analysis of the efficacy and safety of [177Lu]Lu-edotreotide ([177Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumors — Europe PMC PMID:41204752

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41204752
DOI
10.1111/jne.70103
License (as archived)
solo-consultazione
Archived
2026-11-08T17:23:18.978Z
SHA-256 of the archived text
3ce130adb7a171f2ffed09e11d763d63a272d33a86c9affbc353315ecab7408a
Stable URL of this page
https://metraipolis.com/documento/dc_dc8322d7af64

How to cite

Systematic review and meta-analysis of the efficacy and safety of [177Lu]Lu-edotreotide ([177Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumors — Europe PMC PMID:41204752 — Europe PMC (en), https://europepmc.org/article/MED/41204752 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc8322d7af64 (Metraipolis archive dc_dc8322d7af64, sha256 3ce130adb7a171f2ffed09e11d763d63a272d33a86c9affbc353315ecab7408a)
BibTeX
@misc{dcdc8322d7af64,
  title = {Systematic review and meta-analysis of the efficacy and safety of [177Lu]Lu-edotreotide ([177Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumors — Europe PMC PMID:41204752},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41204752},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc8322d7af64; sha256 3ce130adb7a171f2ffed09e11d763d63a272d33a86c9affbc353315ecab7408a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41204752. Agents can read the archived copy with the MCP tool read_document.